脂质体
纳米颗粒
阿霉素
药物输送
磁性纳米粒子
药品
材料科学
纳米技术
癌症
化疗
生物医学工程
毒品携带者
生物物理学
靶向给药
药理学
医学
生物
外科
内科学
作者
Pubudu M. Peiris,Lisa Bauer,Randall Toy,Emily Tran,Jenna Pansky,Elizabeth Doolittle,Erik Schmidt,Elliott Hayden,Aaron T. Mayer,Ruth A. Keri,Mark A. Griswold,Efstathios Karathanasis
出处
期刊:ACS Nano
[American Chemical Society]
日期:2012-04-13
卷期号:6 (5): 4157-4168
被引量:161
摘要
While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target delivery. The nanoparticle is composed of three magnetic nanospheres and one doxorubicin-loaded liposome assembled in a 100 nm long chain. These nanoparticles display prolonged blood circulation and significant intratumoral deposition in tumor models in rodents. Furthermore, the magnetic particles of the chains serve as a mechanical transducer to transfer radio frequency energy to the drug-loaded liposome. The defects on the liposomal walls trigger the release of free drug capable of spreading throughout the entire tumor, which results in a widespread anticancer effect.
科研通智能强力驱动
Strongly Powered by AbleSci AI